======= PRDM8 =======
== Gene Information ==
* **Official Symbol**: PRDM8
* **Official Name**: PR/SET domain 8
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56978|56978]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQV8|Q9NQV8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PRDM8&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRDM8|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/616639|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a protein that belongs to a conserved family of histone methyltransferases that predominantly act as negative regulators of transcription. The encoded protein contains an N-terminal Su(var)3-9, Enhancer-of-zeste, and Trithorax (SET) domain and a double zinc-finger domain. Knockout of this gene in mouse results in mistargeting by neurons of the dorsal telencephalon, abnormal itch-like behavior, and impaired differentiation of rod bipolar cells. In humans, the protein has been shown to interact with the phosphatase laforin and the ubiquitin ligase malin, which regulate glycogen construction in the cytoplasm. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016].
* **UniProt Summary**: Probable histone methyltransferase, preferentially acting on 'Lys-9' of histone H3 (By similarity). Involved in the control of steroidogenesis through transcriptional repression of steroidogenesis marker genes such as CYP17A1 and LHCGR (By similarity). Forms with BHLHE22 a transcriptional repressor complex controlling genes involved in neural development and neuronal differentiation (By similarity). In the retina, it is required for rod bipolar and type 2 OFF-cone bipolar cell survival (By similarity). {ECO:0000250|UniProtKB:Q8BZ97}.
No Pfam Domain information is available for this gene.
|oligodendrocyte development|
|methyltransferase activity|
|oligodendrocyte differentiation|
|glial cell development|
|glial cell differentiation|
|gliogenesis|
|methylation|
|central nervous system development|
|DNA binding|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|neurogenesis|
|cell development|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp183|IU1-C 25μM R04 exp183]]|1.7|
|[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|1.81|
|[[:results:exp332|Adefovir 20μM R07 exp332]]|1.82|
|[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|1.96|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 14730
* **Expression level (log2 read counts)**: -2.21
{{:chemogenomics:nalm6 dist.png?nolink |}}